MicroRNA-30c-2-3p represses malignant progression of gastric adenocarcinoma cells via targeting ARHGAP11A

References

• Lu Z, Luo T, Pang T, et al. MALAT1 promotes gastric adenocarcinoma through the MALAT1/miR-181a-5p/AKT3 axis. Open Biol. 2019;9(190095):190095.
   PubMedGoogle Scholar
• Schwartz GK. Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations. Semin Oncol. 1996;23:316–324.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Kurokawa Y, Mori M, et al. Update on the treatment of gastric cancer. JMA J. 2018;1:40–49.
   PubMedGoogle Scholar
• Lordick F, Siewert JR. Recent advances in multimodal treatment for gastric cancer: a review. Gastric Cancer. 2005;8:78–85.
   PubMedGoogle Scholar
• Fan HN, Chen, Z.Y., Chen, X.Y., et al. METTL14-mediated m(6)A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis. Mol Cancer. 2022;21:51.
   PubMed Web of Science ®Google Scholar
• Kuroda S, Fukata M, Nakagawa M, et al. Cdc42, Rac1, and their effector IQGAP1 as molecular switches for cadherin-mediated cell-cell adhesion. Biochem Biophys Res Commun. 1999;262:1–6.
   PubMed Web of Science ®Google Scholar
• Orgaz JL, Herraiz C, Sanz-Moreno V. Rho GTPases modulate malignant transformation of tumor cells. Small GTPases. 2014;5:e29019.
   PubMedGoogle Scholar
• Csepanyi-Komi R, Safar D, Grosz V, et al. In silico tissue-distribution of human Rho family GTPase activating proteins. Small GTPases. 2013;4:90–101.
   PubMedGoogle Scholar
• Lawson CD, Der CJ. Filling GAPs in our knowledge: ARHGAP11A and RACGAP1 act as oncogenes in basal-like breast cancers. Small GTPases. 2018;9:290–296.
   PubMedGoogle Scholar
• Dai B, Zhang X, Shang R, et al. Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma. Cell Commun Signal. 2018;16:99.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang D, Jiang F, et al. Prognostic prediction using a stemness index-related signature in a cohort of gastric cancer. Front Mol Biosci. 2020;7:570702.
   PubMed Web of Science ®Google Scholar
• Fan B, Ji K, Bu Z, et al. ARHGAP11A is a prognostic biomarker and correlated with immune infiltrates in gastric cancer. Front Mol Biosci. 2021;8:720645.
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Okada, R., Hozaka, Y., et al. Molecular pathogenesis of pancreatic ductal adenocarcinoma: impact of miR-30c-5p and miR-30c-2-3p regulation on oncogenic genes. Cancers (Basel). 2020;12:2731.
   PubMed Web of Science ®Google Scholar
• Shukla K, Sharma AK, Ward A, et al. MicroRNA-30c-2-3p negatively regulates NF-kappaB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer. Mol Oncol. 2015;9:1106–1119.
   PubMed Web of Science ®Google Scholar
• Mathew LK, Lee SS, Skuli N, et al. Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activity. Cancer Discov. 2014;4:53–60.
   PubMed Web of Science ®Google Scholar
• Tang CT, Liang Q, Yang L, et al. RAB31 targeted by MiR-30c-2-3p regulates the GLI1 signaling pathway, affecting gastric cancer cell proliferation and apoptosis. Front Oncol. 2018;8:554.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Peng Z, Zhao Y, et al. microRNA-25 inhibits cell apoptosis of human gastric adenocarcinoma cell line AGS via regulating CCNE1 and MYC. Med Sci Monit. 2016;22:1415–1420.
   PubMed Web of Science ®Google Scholar
• Tang H, Long Q, Zhuang K, et al. miR-665 promotes the progression of gastric adenocarcinoma via elevating FAK activation through targeting SOCS3 and is negatively regulated by lncRNA MEG3. J Cell Physiol. 2020;235:4709–4719.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xie M, Zhang N, et al. miR-1262 suppresses gastric cardia adenocarcinoma via targeting oncogene ULK1. J Cancer. 2021;12:1231–1239.
   PubMed Web of Science ®Google Scholar
• Rezghi Barez S, Movahedian Attar A, Aghaei M. MicroRNA-30c-2-3p regulates ER stress and induces apoptosis in ovarian cancer cells underlying ER stress. EXCLI J. 2021;20:922–934.
   PubMed Web of Science ®Google Scholar
• Chen X, Gao S, Zhao Z, et al. MicroRNA-320d regulates tumor growth and invasion by promoting FoxM1 and predicts poor outcome in gastric cardiac adenocarcinoma. Cell Biosci. 2020;10:80.
   PubMed Web of Science ®Google Scholar
• Wei B, Song Y, Zhang Y, et al. microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2. Oncol Lett. 2013;6:1713–1718.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18:20.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang L-H, Hou J-C, et al. Circular RNA hsa_circ_0072995 promotes breast cancer cell migration and invasion through sponge for miR-30c-2-3p. Epigenomics. 2018;10:1229–1242.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cai M, Jiang D, et al. Upregulated LncRNA-CCAT1 promotes hepatocellular carcinoma progression by functioning as miR-30c-2-3p sponge. Cell Biochem Funct. 2019;37:84–92.
   PubMed Web of Science ®Google Scholar
• Kagawa Y, Matsumoto S, Kamioka Y, et al. Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo. PLoS One. 2013;8:e83629.
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Yashiro M. Rho/ROCK signaling in motility and metastasis of gastric cancer. World J Gastroenterol. 2014;20:13756–13766.
   PubMed Web of Science ®Google Scholar
• Cherfils J, Zeghouf M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev. 2013;93:269–309.
   PubMed Web of Science ®Google Scholar
• Ji W, Zhang L, Zhu H. GATA binding protein 5 (GATA5) induces Rho GTPase activating protein 9 (ARHGAP9) to inhibit the malignant process of lung adenocarcinoma cells. Bioengineered. 2022;13:2878–2888.
   PubMed Web of Science ®Google Scholar
• Guan X, Guan, X., Qin, J., et al. ARHGAP11A promotes the malignant progression of gastric cancer by regulating the stability of actin filaments through TPM1. J Oncol. 2021;2021:4146910.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhou, X., Wang, J., et al. RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain. Cell Rep. 2013;3:1526–1538.
   PubMed Web of Science ®Google Scholar
• Xu S, Zhan M, Wang J. Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks. Cell Death Discov. 2017;3:17069.
   PubMed Web of Science ®Google Scholar